Compellingly high SARS-CoV-2 susceptibility of Golden Syrian hamsters suggests multiple zoonotic infections of pet hamsters during the COVID-19 pandemic

[1]  D. Patil,et al.  Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern , 2022, eBioMedicine.

[2]  M. Koopmans,et al.  Spreading of SARS-CoV-2 from hamsters to humans , 2022, The Lancet.

[3]  L. Poon,et al.  Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study , 2022, The Lancet.

[4]  D. Lung,et al.  Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong , 2022, Emerging microbes & infections.

[5]  R. Baric,et al.  Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model , 2022, mBio.

[6]  Y. Kawaoka,et al.  Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters , 2022, bioRxiv.

[7]  P. Maes,et al.  The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters , 2021, bioRxiv.

[8]  H. Bielefeldt-Ohmann,et al.  Activity of Galidesivir in a Hamster Model of SARS-CoV-2 , 2021, Viruses.

[9]  A. Gruber,et al.  Hamster models of COVID-19 pneumonia reviewed: How human can they be? , 2021, Veterinary pathology.

[10]  Charles B. Stauft,et al.  MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge , 2021, NPJ vaccines.

[11]  S. M. Birch,et al.  Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model , 2021, The Journal of infectious diseases.

[12]  A. Marzi,et al.  Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model , 2021, EBioMedicine.

[13]  S. Parks,et al.  Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection , 2021, Viruses.

[14]  Dongdong Zhang,et al.  The incubation period of COVID-19: a global meta-analysis of 53 studies and a Chinese observation study of 11 545 patients , 2021, Infectious Diseases of Poverty.

[15]  A. Singh,et al.  ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection , 2021, bioRxiv.

[16]  K. Lole,et al.  SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters , 2021, Viruses.

[17]  A. Marzi,et al.  Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model , 2021, bioRxiv.

[18]  M. Beer,et al.  CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2 , 2021, Nature Communications.

[19]  R. Bhopal,et al.  Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses– CORRIGENDUM , 2021, Epidemiology and Infection.

[20]  V. Gerdts,et al.  SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney , 2021, bioRxiv.

[21]  Saikat Basu,et al.  Computational characterization of inhaled droplet transport to the nasopharynx , 2021, Scientific Reports.

[22]  A. Gruber,et al.  SARS‐CoV‐2 infection of Chinese hamsters (Cricetulus griseus) reproduces COVID‐19 pneumonia in a well‐established small animal model , 2020, Transboundary and emerging diseases.

[23]  M. Beer,et al.  Multi‐species ELISA for the detection of antibodies against SARS‐CoV‐2 in animals , 2020, bioRxiv.

[24]  A. Gruber,et al.  The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection , 2020, Cell Reports.

[25]  P. Vanhems,et al.  The incubation period of COVID-19: A meta-analysis , 2020, International Journal of Infectious Diseases.

[26]  M. Beer,et al.  SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study , 2020, The Lancet Microbe.

[27]  S. Alexandersen,et al.  SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication , 2020, Nature Communications.

[28]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[29]  K. To,et al.  Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  H. Feldmann,et al.  Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection , 2020, Emerging microbes & infections.

[31]  Martin Beer,et al.  A Versatile Sample Processing Workflow for Metagenomic Pathogen Detection , 2018, Scientific Reports.

[32]  Amanda P. Beck,et al.  Principles and approaches for reproducible scoring of tissue stains in research , 2018, Laboratory Investigation.

[33]  Alison Twycross,et al.  What is a case study? , 2017, Evidence Based Journals.

[34]  Egon Friedell,et al.  The Incubation Period , 2017 .

[35]  M. Dimatteo,et al.  A Meta-Analysis , 2009 .

[36]  OUP accepted manuscript , 2021, The Journal of Infectious Diseases.

[37]  H. Yen,et al.  Pathogenesis and transmission of SARS-CoV-2 in golden Syrian hamsters , 2020, Nature.

[38]  G. Atkinson.  The Spearman-Karber Method of Estimating 50% Endpoints , 1961 .